Morgan Stanley Upgrades PhenomeX to Equal-Weight, Announces $1 Price Target
Portfolio Pulse from richadhand@benzinga.com
Morgan Stanley analyst Tejas Savant has upgraded PhenomeX (NASDAQ:CELL) from Underweight to Equal-Weight and announced a $1 price target.

August 18, 2023 | 11:55 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
PhenomeX has been upgraded by Morgan Stanley from Underweight to Equal-Weight with a $1 price target.
The upgrade from Morgan Stanley is a positive signal for PhenomeX. The new rating of Equal-Weight suggests that the stock is expected to perform in line with the market, which is an improvement from the previous Underweight rating. The $1 price target also provides a clear expectation for the stock's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100